ABCCX | CLBFX | ABCCX / CLBFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 22 years | - |
Gain YTD | -0.427 | 9.712 | -4% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 108M | 236B | 0% |
Annual Yield % from dividends | 1.03 | 2.39 | 43% |
Returns for 1 year | -0.01 | 10.33 | -0% |
Returns for 3 years | -15.05 | 11.38 | -132% |
Returns for 5 years | -10.11 | 32.81 | -31% |
Returns for 10 years | -13.88 | 67.19 | -21% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PSR | 90.33 | 1.32 | +1.48% |
Invesco Active US Real Estate | |||
HELX | 29.20 | 0.34 | +1.17% |
Franklin Genomic Advancements ETF | |||
SDIV | 20.56 | 0.23 | +1.13% |
Global X SuperDividend™ ETF | |||
SDG | 72.18 | 0.39 | +0.54% |
iShares MSCI Global Sust Dev Goals ETF | |||
IAGG | 50.03 | 0.09 | +0.18% |
iShares Core International Aggt Bd ETF |